Original Article

You have full text access to this OnlineOpen article

Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma

  1. Gong Yang M.D., M.P.H.1,2,†,*,
  2. Xiao-Ou Shu M.D., Ph.D.1,2,
  3. Zhi-Xian Ruan B.S.3,
  4. Qiu-Yin Cai M.D., Ph.D.1,2,
  5. Fan Jin M.D.3,
  6. Yu-Tang Gao M.D.3,
  7. Wei Zheng M.D., Ph.D.1,2

Article first published online: 24 NOV 2004

DOI: 10.1002/cncr.20729

Issue

Cancer

Cancer

Volume 103, Issue 1, pages 52–58, 1 January 2005

Additional Information

How to Cite

Yang, G., Shu, X.-O., Ruan, Z.-X., Cai, Q.-Y., Jin, F., Gao, Y.-T. and Zheng, W. (2005), Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer, 103: 52–58. doi: 10.1002/cncr.20729

Author Information

  1. 1

    Vanderbilt Center for Health Services Research, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

  2. 2

    Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

  3. 3

    Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China

  1. †

    Fax: (615) 936-1269

*Vanderbilt University Medical Center, Center for Health Services Research, 6111 Medical Center East, 1215 21st Avenue South, Nashville, TN 37232-8300

  1. †

    Fax: (615) 936-1269

Publication History

  1. Issue published online: 17 DEC 2004
  2. Article first published online: 24 NOV 2004
  3. Manuscript Accepted: 15 SEP 2004
  4. Manuscript Revised: 10 SEP 2004
  5. Manuscript Received: 26 JUL 2004

Funded by

  • United States Public Health Service. Grant Number: RO1CA64277
  • National Cancer Institute. Grant Number: RO1CA90899

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (101K)

REFERENCES

  • 1
    Russin MR, Goldstein LJ. Chemotherapy in breast cancer. In: TorosianMH, editor. Breast cancer. Totowa, NJ: Humana Press, 2002: 145–159.
  • 2
    Iqbal S, Lenz HJ. Targeted therapy and pharmacogenomic programs. Cancer. 2003; 97(8 Suppl ): 2076–2082.
    Direct Link:
  • 3
    Nagasubramanian R, Innocenti F, Ratain MJ. Pharmacogenetics in cancer treatment. Annu Rev Med. 2003; 54: 437–452.
  • 4
    Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors. 2003; 17: 115–130.
    Direct Link:
  • 5
    Stearns V, Davidson NE, Flockhart DA. Pharmacogenetics in the treatment of breast cancer. Pharmacogenomics J. 2004; 4: 143–153.
  • 6
    Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995; 30: 445–600.
  • 7
    London SJ, Yuan JM, Chung FL, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet. 2000; 356: 724–729.
  • 8
    Hamajima N, Takezaki T, Tajima K. Allele frequencies of 25 polymorphisms pertaining to cancer risk for Japanese, Koreans and Chinese. Asian Pac J Cancer Prev. 2002; 3: 197–206.
  • 9
    Park SK, Yoo KY, Lee SJ, et al. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics. 2000; 10: 301–309.
  • 10
    Srivastava SK, Singhal SS, Hu X, Awasthi YC, Zimniak P, Singh SV. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys. 1999; 366: 89–94.
  • 11
    Pandya U, Srivastava SK, Singhal SS, et al. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochem Biophys Res Commun. 2000; 278: 258–262.
  • 12
    Lizard-Nacol S, Coudert B, Colosetti P, Riedinger JM, Fargeot P, Brunet-Lecomte P. Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer. Breast Cancer Res. 1999; 1: 81–87.
  • 13
    Ambrosone CB, Sweeney C, Coles BF, et al. Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. Cancer Res. 2001; 61: 7130–7135.
  • 14
    Sweeney C, McClure GY, Fares MY, et al. Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism. Cancer Res. 2000; 60: 5621–5624.
  • 15
    Goode EL, Dunning AM, Kuschel B, et al. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res. 2002; 62: 3052–3057.
  • 16
    Sweeney C, Ambrosone CB, Joseph L, et al. Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer. 2003; 103: 810–814.
    Direct Link:
  • 17
    Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2000; 87: 295–300.
    Direct Link:
  • 18
    Shu XO, Gao YT, Cai Q, et al. Genetic polymorphisms in the TGF-β1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res. 2004; 64: 836–839.
  • 19
    Egan KM, Cai Q, Shu XO, et al. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2004; 13: 197–204.
  • 20
    Salinas AE, Wong MG. Glutathione S-transferases—a review. Curr Med Chem. 1999; 6: 279–309.
  • 21
    Huang J, Tan PH, Thiyagarajan J, Bay BH. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol. 2003; 16: 558–565.
  • 22
    Boku N, Chin K, Hosokawa K, et al. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum. Clin Cancer Res. 1998; 4: 1469–1474.
  • 23
    Harpole DH Jr., Moore MB, Herndon JE II, et al. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res. 2001; 7: 562–569.
  • 24
    Yokoyama Y, Sato S, Fukushi Y, Sakamoto T, Futagami M, Saito Y. Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res. 1999; 25: 387–394.
    Direct Link:
  • 25
    Kigawa J, Minagawa Y, Kanamori Y, et al. Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer. Cancer. 1998; 82: 697–702.
    Direct Link:
  • 26
    Shiga H, Heath EI, Rasmussen AA, et al. Prognostic value of p53, glutathione S-transferase π, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res. 1999; 5: 4097–4104.
  • 27
    Stoehlmacher J, Park DJ, Zhang W, et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2002; 94: 936–942.
  • 28
    Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res. 1998; 58: 65–70.
  • 29
    Lallas TA, McClain SK, Shahin MS, Buller RE. The glutathione S-transferase M1 genotype in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2000; 9: 587–590.
  • 30
    Yang P, Yokomizo A, Tazelaar HD, et al. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer. 2002; 35: 221–229.
  • 31
    Sala A, Lanciotti M, Valsecchi MG, et al. Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia. Leukemia. 2003; 17: 981–983.
  • 32
    Davies SM, Bhatia S, Ross JA, et al. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood. 2002; 100: 67–71.
  • 33
    Howells RE, Redman CW, Dhar KK, et al. Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin Cancer Res. 1998; 4: 2439–2445.
  • 34
    Sweeney C, Nazar-Stewart V, Stapleton PL, Eaton DL, Vaughan TL. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2003; 12: 527–533.
  • 35
    Voso MT, D'Alo' F, Putzulu R, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood. 2002; 100: 2703–2707.
  • 36
    Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol. 2001; 19: 1279–1287.
View Full Article (HTML) Get PDF (101K)